If your lab report shows a reactive RPR test, the most useful thing to know first is this: a positive RPR test is not a syphilis diagnosis. The RPR is a screening test. It is built to be sensitive rather than precise, and it is always meant to be paired with a second, more specific test before anyone reaches a conclusion. Biological false positives are common and well documented. And when syphilis is confirmed, it is curable with antibiotics prescribed by a doctor.
In this article you’ll learn what the RPR actually measures, why laboratories never read it on its own, how the two testing algorithms work, what the titer number means, why a very high antibody level can read as negative, and when to talk to a clinician.
What the RPR test measures — and what it does not
RPR stands for rapid plasma reagin, and the important detail sits inside that name: reagin. The test does not look for Treponema pallidum, the bacterium that causes syphilis. It never touches the organism at all.
Instead, the RPR detects antibodies your immune system makes against lipid material released when cells are damaged. Syphilis causes that kind of damage, so the antibodies often appear during infection. But other conditions damage cells in similar ways and trigger the same antibodies. This is why the RPR is called a nontreponemal test: it measures a downstream consequence, not the cause.
That design is a feature, not a flaw. A nontreponemal test is quick, cheap and easy to run at scale, which makes it excellent for screening a whole population. The trade-off is precision. Laboratories group the RPR with other serology tests that detect antibodies rather than organisms.
Treponemal tests: the other half of the picture
A treponemal test does the opposite job: it looks for antibodies aimed specifically at Treponema pallidum itself. Common examples include TP-PA (T. pallidum particle agglutination), FTA-ABS (fluorescent treponemal antibody absorption), and automated treponemal immunoassays such as EIA or CLIA.
Neither test is complete on its own. The RPR suggests whether something is active; a treponemal test indicates whether Treponema pallidum was ever involved. Only together do they mean anything — which is why StatPearls states that a reactive nontreponemal result always requires confirmation with a treponemal assay.
Why the RPR is never read alone: the two testing algorithms
US laboratories use one of two sequences, and which one your lab uses explains why your report looks the way it does.
The traditional algorithm
The traditional sequence runs the RPR first. If it is nonreactive, testing usually stops. If it is reactive, the laboratory runs a treponemal test to confirm or exclude syphilis — cheap screen first, specific confirmation second.
The reverse-sequence algorithm
Many US laboratories have switched the order, because modern treponemal immunoassays can be automated and run at scale. The reverse sequence starts with a treponemal test, typically an EIA or CLIA. If it is negative, testing stops. If it is positive, the laboratory then runs an RPR. If the two disagree — treponemal positive but RPR negative — a second, different treponemal test such as TP-PA settles the question.
This is the most common source of confusion for readers. Under the reverse sequence, it is entirely normal to see “treponemal antibody: positive” and “RPR: nonreactive” side by side. That combination looks contradictory, but usually is not. Most often it means a syphilis infection treated in the past, where treponemal antibodies persist but the RPR has settled back down. Occasionally it means very early infection, and occasionally the first treponemal test was itself falsely positive. That is exactly why the third test exists.
Why treponemal tests stay positive for life
Once your immune system has met Treponema pallidum, it remembers. Treponemal antibodies typically persist indefinitely, whether or not the infection was cured, so in most people who have had syphilis a treponemal test reads positive for life.
Two consequences follow. A treponemal test cannot distinguish a current infection from one successfully treated twenty years ago, and it cannot monitor treatment, because it does not fall. The same immunological memory shows up in immunoglobulin G (IgG) results generally, whereas immunoglobulin M (IgM) signals a more recent event. Readers who have navigated toxoplasmosis IgG and IgM results will recognise the same logic.
Reading your results: what each combination means
Because neither test means anything alone, interpretation lives in the combination. The table covers the patterns most people see on a report.
| RPR (nontreponemal) | Treponemal test | Usual interpretation | Usual next step |
|---|---|---|---|
| Nonreactive | Nonreactive or not performed | No serological evidence of syphilis | No further testing, unless there was a possible exposure in the past few weeks |
| Reactive, usually at a low titre | Nonreactive | Biological false positive — the RPR is reacting to something other than syphilis | A doctor looks for the underlying cause; no syphilis treatment is indicated |
| Reactive | Reactive | Syphilis — either a current infection, or one already treated in the past | A doctor reviews the titre, any symptoms and previous results to tell current from past |
| Nonreactive | Reactive | Most often a past, treated infection; sometimes very early syphilis; occasionally a falsely positive treponemal test | A second, different treponemal test (usually TP-PA) resolves the discordance |
| Nonreactive | Not performed, but there are symptoms or a recent possible exposure | Possibly too early — antibodies take a few weeks to appear | Repeat testing after several weeks, as advised by a clinician |
In four of the five rows, the honest answer is a second test rather than a verdict. Confirmation is not a sign that something went wrong — it is how the system is designed to work.
Biological false positives: why a reactive RPR often is not syphilis
Because the RPR measures antibodies to cell damage rather than to the bacterium, anything producing similar damage can make it reactive. Clinicians have recognised this for decades and named it: the biological false positive. StatPearls puts the rate in the United States at roughly 1% to 2% of people tested — across millions of screening tests, a very large number of people.
Well-recognised causes include:
- Pregnancy, one of the most common reasons of all
- Autoimmune conditions, especially lupus and antiphospholipid syndrome
- Injection drug use
- Older age
- Recent vaccination
- Other infections, including infectious mononucleosis, hepatitis, HIV, malaria and Lyme disease
All of these involve immune activation or cell turnover. The RPR is doing exactly what it was designed to do; it simply cannot tell which kind of cell damage it is detecting.
The classic pattern is a reactive RPR at a low titre — often 1:8 or below — with a nonreactive treponemal test. If your report shows that combination, the treponemal test carries the weight, because it is the specific one. The antibodies involved overlap with those measured by markers such as antinuclear antibodies (ANA), and a raised C-reactive protein (CRP) often accompanies the same inflammation.
What the RPR titer means and how it tracks treatment
When an RPR is reactive, the laboratory reports a titer: 1:1, 1:8, 1:32, 1:64 and so on. The titer is simply the furthest the laboratory could dilute your sample and still see a reaction. A higher second number means more antibody. It does not measure how ill you are, and it is not a score of anything about you as a person.
Titers matter for two reasons. Higher titers track more active infection — untreated secondary syphilis often runs at 1:32 or above. More importantly, titers are how doctors confirm treatment worked.
The fourfold rule
Because titers move in doubling steps, clinicians look for a fourfold change — two steps on the dilution scale. A fourfold drop, 1:32 falling to 1:8, indicates that treatment is doing its job. A fourfold rise in someone previously treated suggests reinfection or a treatment that did not fully work, and prompts a fresh look. This is why the RPR is irreplaceable: it is the only half of the pair that can do this.
The serofast state
Here is a fact that spares a lot of unnecessary worry. In roughly one in five people treated for early syphilis, the titer never fully clears. It drops, then plateaus at a low level — 1:4 or 1:8 — and stays there, sometimes permanently, with no symptoms and no sign of ongoing infection. This is the serofast state.
It is not treatment failure. Current understanding is that it reflects a lingering immune pattern rather than surviving bacteria. A titer that settled at a low number and stopped moving is a recognised, well-described outcome.
False negatives and the prozone phenomenon
The RPR can also miss syphilis. The most common reason is testing too early, before antibodies have developed. It is also less sensitive in very early primary syphilis and in late-stage disease than in the secondary and latent stages.
Then there is a counterintuitive trap. The RPR works by antibodies clumping with test antigen into visible aggregates, and that clumping needs a rough balance between the two. In secondary syphilis, antibody levels can be so high that they swamp the antigen and block the clumping altogether. The undiluted sample then looks perfectly clean — a false negative caused by too much antibody rather than too little.
This is the prozone phenomenon. It is uncommon but real, and it appears where a missed diagnosis matters most: florid, highly infectious secondary syphilis. The fix is simple and laboratories know it well — dilute the sample and re-run it, and the reaction appears. If you have symptoms consistent with secondary syphilis, such as a rash on the palms or soles, tell your clinician, because clinical suspicion prompts the laboratory to dilute.
Who is screened for syphilis, and why it is routine care
Syphilis screening is ordinary healthcare, not an accusation and not a judgement. It is frequently included in standard panels, and many people encounter an RPR without ever having requested one.
US syphilis rates, including congenital syphilis, have risen substantially over the past two decades, which is why national bodies have expanded screening recommendations. The US Preventive Services Task Force gives a grade A recommendation — its strongest — for screening asymptomatic adolescents and adults at increased risk for syphilis. The CDC additionally recommends regular screening for several groups, including people living with HIV and people taking PrEP. If syphilis screening has been recommended to you, it reflects a testing policy, not an assumption about your life.
Screening in pregnancy
Screening in pregnancy is universal, not selective. The CDC recommends that every pregnant person be tested at the first prenatal visit, with repeat testing at 28 weeks and delivery in some circumstances, and the USPSTF likewise recommends early universal screening. Because it applies to everyone, an RPR on a prenatal panel says nothing whatsoever about an individual.
The reason is straightforward: congenital syphilis is preventable when syphilis in pregnancy is found and treated in time. Treatment during pregnancy protects the baby. This is also the setting where biological false positives are most frequent, since pregnancy itself is a well-known cause — one more reason a reactive RPR in pregnancy prompts a confirmatory test rather than a conclusion. The RPR usually sits alongside other blood tests during pregnancy, including the hepatitis B surface antigen test and an HIV screening test.
When to talk to a doctor
An RPR result — whatever it says — is a reason for a conversation, not a reason to draw conclusions alone. A clinician sees your titer, history, previous results and symptoms together, which is the only way any of it means anything.
Contact a healthcare professional if:
- Your RPR is reactive — whatever the titre, and whatever the treponemal test shows
- Your report shows a treponemal test and an RPR that disagree with each other
- You have a painless sore, or a rash on your palms or the soles of your feet
- You are pregnant and any syphilis test on your panel was reactive
- You were treated for syphilis and your titre has risen, or has not fallen as expected
- You have unexplained headaches, vision changes or hearing changes alongside a reactive result
Syphilis is curable. Treatment is with penicillin, prescribed and dosed by a doctor, and it works. Confirmatory testing is what makes that possible.
The anti-HCV hepatitis C test follows a screen-then-confirm logic very similar to the RPR, and our guide covers how to read blood test results in general.
Latest scientific advances in syphilis testing
Research published in 2025 and 2026 has sharpened several of the points above.
The reverse-sequence algorithm finds slightly more, but overtreats more too
A team including CDC researchers modelled both algorithms in prenatal care, simulating 10,000 pregnancies. The reverse sequence detected four additional cases and prevented a fraction of a congenital syphilis case, but it also led to 185 more people being treated who did not need treatment, and cost considerably more per unit of health gained. The authors concluded that in typical US prenatal settings the reverse sequence is about equally effective but not cost effective.
What this means for you: nothing about your own care changes, but it explains why laboratories legitimately choose different sequences — and confirms that overtreatment after a reverse-sequence screen is a recognised trade-off rather than a mistake about you.
Discordant results depend partly on which algorithm your lab follows
A 2026 study compared the CDC and European (ECDC) versions of the reverse sequence across 82 samples reactive on an initial automated treponemal test. The two agreed 96.3% of the time, and disagreements clustered exactly where you would expect — samples with a reactive RPR but a nonreactive second treponemal test. In two cases, follow-up suggested genuine early active syphilis.
What this means for you: if your results look contradictory, you are seeing the known hard edge of syphilis serology, not a broken test. It also shows why clinicians sometimes repeat testing after an interval instead of deciding immediately — in early infection the picture genuinely changes over weeks.
False positives are not always low-titre
A Japanese study reviewed eight years of testing and identified 154 confirmed biological false positives. Most were low-level, and the most common associated conditions were cancers, digestive diseases and infections. But cases linked to Epstein-Barr virus mononucleosis stood out sharply: in teenagers and young adults, they produced strikingly high RPR levels that mimicked active syphilis.
What this means for you: the common teaching that false positives are always low-titer is a useful rule of thumb, not an absolute one. A high RPR in a young person with a sore throat, fever and swollen glands may reflect mononucleosis rather than syphilis — which reinforces the central message that the treponemal test, not the titer, is what distinguishes them.
The serofast state looks like immune memory, not surviving infection
Two 2026 studies examined people whose titers stayed up after treatment. One followed 33 adults treated for early syphilis and found that the eight serofast individuals showed a distinct immune signature — sustained B-cell activation and altered clotting measurements — rather than evidence of persisting bacteria. The authors called it an infection-triggered immune phenotype rather than ongoing infection.
A larger cohort followed 184 people living with HIV through a first episode of syphilis. Most responded: 84% reached a fourfold titer drop by 12 months and 89% by 24 months. Around half of those who responded then remained serofast, and nearly half of that group eventually cleared completely — some taking over two years. Slower responses tracked with syphilis stage and immune status, not treatment failure.
What this means for you: if you have been treated and your titer has stalled at a low level, current evidence supports the reassuring interpretation — and it may simply be slow. A titer that has not moved for months is not, by itself, evidence that anything is wrong. These findings come from small studies and observational cohorts, so they describe patterns rather than prove causes. Your doctor remains the person to interpret your particular numbers.
Glossary
| Term | Definition |
|---|---|
| RPR (rapid plasma reagin) | A blood screening test that detects antibodies to cell damage, not to the syphilis bacterium itself |
| Nontreponemal test | A test such as RPR or VDRL that measures a general immune reaction rather than the organism; sensitive but not specific |
| Treponemal test | A test such as TP-PA, FTA-ABS or a treponemal EIA that detects antibodies aimed specifically at Treponema pallidum |
| Titer | How far a sample can be diluted and still react, written as 1:8 or 1:32; a higher second number means more antibody |
| Fourfold change | A two-step move on the dilution scale, such as 1:32 to 1:8; a fourfold drop indicates successful treatment |
| Reverse-sequence algorithm | A testing order, now common in US labs, that runs an automated treponemal test first and the RPR second |
| Biological false positive | A reactive RPR caused by something other than syphilis, confirmed by a nonreactive treponemal test |
| Prozone phenomenon | A false-negative RPR caused by an extremely high antibody level blocking the reaction; diluting the sample reveals it |
| Serofast state | A titer that drops after treatment but plateaus at a low level instead of clearing; not treatment failure |
| Congenital syphilis | Syphilis passed to a baby during pregnancy; preventable when syphilis is detected and treated in time |
Frequently asked questions
Does a positive RPR mean I have syphilis?
No. A reactive RPR means a screening test picked up antibodies that may come from syphilis — and may not. Roughly 1% to 2% of RPR tests in the United States are biological false positives, triggered by pregnancy, autoimmune conditions, other infections, recent vaccination or older age. Only a treponemal test, which looks specifically for the syphilis bacterium, can tell the difference. A reactive RPR with a nonreactive treponemal test is a false positive and does not call for syphilis treatment. Waiting for that second result is a normal, expected part of the process rather than a delay.
What does my RPR titer mean?
The titer is a dilution ratio showing how much antibody is present. A titer of 1:32 means the reaction was still visible after diluting the sample 32-fold, so there is more antibody than at 1:4. Broadly, higher titers suggest more active infection, and untreated secondary syphilis often runs at 1:32 or above. The titer’s most valuable role is tracking treatment: a fourfold drop, such as 1:32 falling to 1:8, shows that treatment worked. On its own, though, a single titer cannot diagnose anything — it needs the treponemal test and your clinical history beside it.
My treponemal test is positive but my RPR is negative. What does that mean?
This combination is common under the reverse-sequence algorithm and it usually is not bad news. Most often it reflects a syphilis infection treated in the past, because treponemal antibodies persist for life while the RPR falls back to nonreactive. It can also mean very early infection before the RPR has risen, or occasionally a falsely positive treponemal test. Laboratories resolve this by running a second, different treponemal test such as TP-PA. Your doctor will weigh that result together with your history and any previous testing.
Can an RPR be negative if I do have syphilis?
Yes, in a few situations. The most common is testing too early, before your immune system has produced enough antibody — this takes several weeks after exposure. The RPR is also less sensitive in very early primary syphilis and in late-stage disease. Less commonly, the prozone phenomenon can produce a false negative when antibody levels are so high that they block the test reaction, which happens in secondary syphilis. Laboratories correct this by diluting the sample. Telling your clinician about symptoms or a possible exposure is what makes sure the right follow-up happens.
Why does everyone get an RPR in pregnancy?
Because screening in pregnancy is universal, not targeted. The CDC recommends syphilis testing for every pregnant person at the first antenatal visit, with repeat testing at 28 weeks and delivery in some circumstances, and the USPSTF recommends early universal screening too. It appears on your panel because you are pregnant — that is the whole reason. Congenital syphilis is preventable when syphilis is found and treated during pregnancy. Pregnancy is also one of the most common causes of a biological false positive, which is another reason a reactive result leads to a confirmatory test rather than a diagnosis.
I was treated, but my titre never went to zero. Is the infection still there?
Probably not. About one in five people treated for early syphilis end up in what clinicians call the serofast state: the titre falls, then plateaus at a low level such as 1:4 or 1:8 and stays there, sometimes for good. Recent research suggests this reflects a lasting immune pattern rather than surviving bacteria. It is also sometimes just slow — titres can take one to two years to settle, and some people clear even later. What matters is that the titre fell fourfold and is not rising. Your doctor can confirm where you stand.
Sources
- Centers for Disease Control and Prevention — About Syphilis
- MedlinePlus, National Library of Medicine — Syphilis Tests
- US Preventive Services Task Force — Syphilis Infection During Pregnancy: Screening
- Zubair M, Launico MV. Rapid Plasma Reagin. StatPearls, NCBI Bookshelf, updated January 2026
- Saldarriaga EM, Pollock ED, Jackson DA, Gift TL, Barbee LA, Bachmann LH, Spicknall IH. Cost Effectiveness of the Reverse Sequence Algorithm Compared With the Traditional Algorithm for Syphilis Screening Among Pregnant Women. Obstetrics and Gynecology, 2025. https://doi.org/10.1097/AOG.0000000000006019
- Karpuz T, Ongut G, Ozyurt OK, Yazisiz H, Turkoglu MA, Felek R, Ogunc D, Mutlu D, Donmez L, Inan D, Colak D. Comparison of CDC and ECDC reverse sequence algorithms for syphilis diagnosis: clinical implications of discordant serological results. BMC Infectious Diseases, 2026. https://doi.org/10.1186/s12879-026-13814-5
- Matsuura N, Matono T, Kuroki M, Saitou K. Epstein-Barr virus-associated infectious mononucleosis exhibits substantially higher non-treponemal test titres in biological false-positive reactions. Journal of Infection and Chemotherapy, 2025. https://doi.org/10.1016/j.jiac.2025.102738
- Kiolbasa M, Kaminiow K, Kadylak D, Pastuszczak M. Serofast Syphilis Is Associated with Phospholipid-Dependent Coagulation Abnormalities and B-Cell Activation Following Treatment. International Journal of Molecular Sciences, 2026. https://doi.org/10.3390/ijms27114954
- Casado JL, Vizcarra P, Izuzquiza I, Rodriguez-Dominguez MJ, Romero-Hernandez B, Moreno A, Vallejo A. Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study. Clinical Infectious Diseases, 2026. https://doi.org/10.1093/cid/ciag193
Further reading
- HIV screening test results
- HBs antigen and hepatitis B
- Anti-HCV and hepatitis C
- Toxoplasmosis IgG and IgM blood results
- Serology tests explained
Understand your lab results with AI DiagMe
An RPR, a treponemal antibody test and an HIV screening test often land on the same report, in language that assumes you already know how screening works. AI DiagMe reads your lab report and explains what each line measures and how the results relate to one another, in plain English. It helps you understand your results and prepare better questions — it does not diagnose you, and it does not replace your doctor.
Get your results interpreted in minutes
